| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.10B | 10.92B | 10.90B | 10.53B | 11.88B | 11.01B |
| Gross Profit | 6.00B | 5.78B | 5.93B | 6.08B | 6.73B | 6.48B |
| EBITDA | 1.53B | 1.47B | 84.16M | 1.12B | 1.36B | 1.18B |
| Net Income | 663.90M | 591.63M | -628.79M | 510.09M | 715.41M | 829.92M |
Balance Sheet | ||||||
| Total Assets | 10.98B | 11.42B | 10.87B | 11.44B | 8.87B | 8.21B |
| Cash, Cash Equivalents and Short-Term Investments | 5.04B | 4.92B | 4.36B | 3.61B | 3.62B | 3.62B |
| Total Debt | 600.00M | 1.19B | 1.48B | 1.57B | 172.15M | 0.00 |
| Total Liabilities | 8.61B | 9.03B | 9.06B | 8.75B | 5.92B | 5.67B |
| Stockholders Equity | 2.37B | 2.39B | 1.81B | 2.69B | 2.93B | 2.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 901.23M | 1.38B | -708.88M | 338.84M | 892.51M |
| Operating Cash Flow | 0.00 | 1.21B | 1.78B | -213.40M | 669.08M | 1.25B |
| Investing Cash Flow | 0.00 | -292.00M | -325.63M | -510.15M | -278.35M | -5.65M |
| Financing Cash Flow | 0.00 | -361.39M | -702.63M | 712.28M | -392.52M | -78.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥24.96B | 19.09 | ― | 4.45% | 17.22% | 10.53% | |
78 Outperform | ¥7.31B | 18.84 | ― | 1.06% | 7.69% | -6.56% | |
76 Outperform | ¥11.17B | 25.60 | ― | 0.47% | 21.21% | 82.61% | |
70 Outperform | ¥11.01B | 16.47 | ― | 2.54% | 3.28% | 13.20% | |
66 Neutral | ¥31.58B | 26.55 | ― | ― | 4.86% | 7.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥128.93B | 50.17 | ― | 0.12% | 45.51% | 292.77% |
GMO Pepabo, Inc. reported its consolidated financial results for the first half of 2025, showing a 3.2% increase in net sales to 5,539 million yen and a significant rise in operating profit by 20.3% compared to the same period last year. The company also announced a forecast for the full fiscal year ending December 31, 2025, with expectations of a 2.4% increase in net sales and a 7.2% rise in operating profit, indicating a positive outlook despite anticipated declines in ordinary profit and profit attributable to owners of the parent.